Chih-Chung Lin

Chih-Chung Lin, also known as Jerry Lin, is a prominent researcher currently serving as an Instructor at both Harvard Medical School and Massachusetts General Hospital (MGH) in Cambridge, Massachusetts. His academic journey includes a significant tenure as a Postdoctoral Researcher at MGH from June 2017 until October 2023, where he focused on the interplay between immune cells and Alzheimer's disease (AD) models.

Educational Background

• Ph.D. in Immunology from Washington University in St. Louis (2011-2017).
• Bachelor's degree in Immunology from National Taiwan University (2005-2009).
• Completed his high school education at Taipei Municipal Jianguo High School (2002-2005).

Research Focus

Dr. Lin's research primarily investigates the roles of immune cells in the pathogenesis of Alzheimer's disease. He has contributed to understanding how peripheral immune cells, including mast cells, affect cognitive functions and neuroinflammation in AD models. His findings indicate that the absence of mast cells in AD mice leads to improved cognitive performance and changes in microglial gene expression, highlighting the complex relationship between immune response and neurodegenerative processes.124

Professional Experience

• Co-founder and Director of Open Box Science since July 2020.
• Engaged in various research initiatives at MGH's Genetics and Aging Research Unit under Dr. Rudolph Tanzi, a leading figure in Alzheimer's research.34

Skills and Languages

Dr. Lin is proficient in both Mandarin Chinese (native) and English (professional working proficiency), which enhances his ability to collaborate internationally within the scientific community.1

Chih-Chung Lin's work is pivotal in advancing our understanding of Alzheimer's disease, particularly through the lens of immunology, making him a valuable asset to both MGH and Harvard Medical School.